| Original language | English |
|---|---|
| Pages (from-to) | 145-147 |
| Number of pages | 3 |
| Journal | Lung Cancer |
| Volume | 136 |
| DOIs | |
| Publication status | Published - Oct 2019 |
| Event | 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) - Barcelona, SPAIN, Milan, Italy Duration: 26 Apr 2019 → 30 Apr 2019 Conference number: 37 |
Keywords
- Small-cell lung cancer
- Limited-stage
- Thoracic radiotherapy
- Fractionation
- THORACIC RADIOTHERAPY
- IRRADIATION
Cite this
}
Current management of limited-stage SCLC and CONVERT trial impact : Results of the EORTC Lung Cancer Group survey. /; Levy, Antonin; Hendriks, Lizza E. L.; Le Pechoux, Cecile; Falk, Sally; Besse, Benjamin; Novello, Silvia; Dingemans, Anne-Marie C.; Hasan, Baktiar; Reck, Martin; Berghmans, Thierry; Faivre-Finn, Corinne.
In: Lung Cancer, Vol. 136, 10.2019, p. 145-147.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Current management of limited-stage SCLC and CONVERT trial impact
T2 - Results of the EORTC Lung Cancer Group survey
AU - Levy, Antonin
AU - Hendriks, Lizza E. L.
AU - Le Pechoux, Cecile
AU - Falk, Sally
AU - Besse, Benjamin
AU - Novello, Silvia
AU - Dingemans, Anne-Marie C.
AU - Hasan, Baktiar
AU - Reck, Martin
AU - Berghmans, Thierry
AU - Faivre-Finn, Corinne
PY - 2019/10
Y1 - 2019/10
KW - Small-cell lung cancer
KW - Limited-stage
KW - Thoracic radiotherapy
KW - Fractionation
KW - THORACIC RADIOTHERAPY
KW - IRRADIATION
U2 - 10.1016/j.lungcan.2019.08.007
DO - 10.1016/j.lungcan.2019.08.007
M3 - Article
VL - 136
SP - 145
EP - 147
JO - Lung Cancer
JF - Lung Cancer
SN - 0169-5002
ER -